Data / Form D filings / Iantrek, Inc.
Iantrek, Inc.: Form D filings
Iantrek, Inc., a biotechnology company in White Plains, NY, filed 4 Form D notices with the SEC between 2020 and 2025. The latest, on August 21, 2025, reports $34.7 million sold of a $42 million offering to 21 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 151 EAST POST ROAD, SUITE 111, White Plains, NY, 10601
- Phone
- (914) 708-6540
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1829982
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 21, 2025 | New notice | $41,986,763 | $34,748,596 | $7,238,167 | 21 | Aug 19, 2025 | sec.gov |
| Feb 26, 2025 | New notice | $5,500,000 | $2,780,366 | $2,719,634 | 4 | Feb 14, 2025 | sec.gov |
| Aug 17, 2022 | New notice | $25,006,934 | $15,410,669 | $9,596,265 | 25 | Aug 4, 2022 | sec.gov |
| Oct 26, 2020 | New notice | $5,223,426 | $5,223,426 | 29 | Oct 16, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tsontcho Ianchulev | Executive Officer, Director | |
| Todd K. Sone | Director | |
| James Mazzo | Director | |
| Adam K. Szaronos | Executive Officer, Director | |
| Casey K. Tansey | Director | |
| Robert K. Weinreb | Director | |
| Marc-Andre Marcotte | Director | |
| Jeffry K. Weinhuff | Director | |
| Michael Haydin | Executive Officer | |
| Farrell Tyson | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Aug 18, 2025 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Iantrek, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.